Estrongenic Steroid Hormones in Lung Cancer

Jill M. Siegfried, Laura P. Stabile

Research output: Contribution to journalArticlepeer-review

93 Scopus citations


It is becoming increasingly clear that steroid hormones are involved in the biology of many organs outside the reproductive system. Evidence has been accumulating since the mid 1990s that the lung contains receptors for both estrogen and progesterone and that these hormones have some role in lung development, pulmonary inflammation, and lung cancer. The estrogen receptor β (ERβ) is the major ER expressed in lung tissues, while inflammatory cells capable of infiltrating the lung are reported to express both ERα and ERβ. Although there is evidence in animals of preferential effects of ERβ in the lungs of females, human lung tumors from males also contain ERβ-positive cells and express aromatase, the enzyme that converts testosterone to estrogens. This review will discuss current literature findings on the role of the ERs and the progesterone receptor (PR), as well CYP19 (aromatase), the rate-limiting enzyme in the synthesis of estrogen, in lung cancer.

Original languageEnglish (US)
Pages (from-to)5-16
Number of pages12
JournalSeminars in Oncology
Issue number1
StatePublished - Feb 2014

Bibliographical note

Funding Information:
This work was supported in part by the following grants: SPORE in Lung Cancer P50 090440 from the National Cancer Institute to J.M.S. , Career Development Award from the SPORE in Lung Cancer P50 090440 to L.P.S., an award from the V Foundation for Cancer Research to J.M.S., and an award from the Lung Cancer Research Foundation to L.P.S.


Dive into the research topics of 'Estrongenic Steroid Hormones in Lung Cancer'. Together they form a unique fingerprint.

Cite this